Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank44
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P44
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -0.95% |
| Q2 2025 | -11.03% |
| Q1 2025 | -9.23% |
| Q4 2024 | -22.26% |
| Q3 2024 | 17.00% |
| Q2 2024 | 24.13% |
| Q1 2024 | 5.42% |
| Q4 2023 | 1.48% |
| Q3 2023 | 18.51% |
| Q2 2023 | -24.43% |
| Q1 2023 | 23.98% |
| Q4 2022 | 2.32% |
| Q3 2022 | -57.17% |
| Q2 2022 | 33.59% |
| Q1 2022 | 76.77% |
| Q4 2021 | -15.40% |
| Q3 2021 | -41.31% |
| Q2 2021 | 98.39% |
| Q1 2021 | -49.50% |
| Q4 2020 | -10.04% |
| Q3 2020 | -1.57% |
| Q2 2020 | -3.17% |
| Q1 2020 | 0.29% |
| Q4 2019 | 10.85% |
| Q3 2019 | -16.65% |
| Q2 2019 | 27.95% |
| Q1 2019 | 14.32% |
| Q4 2018 | -0.66% |
| Q3 2018 | 6.18% |
| Q2 2018 | -4.84% |
| Q1 2018 | 6.75% |
| Q4 2017 | -7.91% |
| Q3 2017 | 2.83% |
| Q2 2017 | -8.99% |
| Q1 2017 | 9.36% |
| Q4 2016 | -0.09% |
| Q3 2016 | -1.01% |
| Q2 2016 | 30.18% |
| Q1 2016 | -16.82% |
| Q4 2015 | 5.34% |